Ares Capital Corporation (ARCC) - 2013 Annual Report Summary
Business Context and Reporting Period
This summary covers the Form 10-K for Ares Capital Corporation for the fiscal year ended December 31, 2013. Ares Capital is a closed-end, non-diversified management investment company regulated as a Business Development Company (BDC). It is externally managed by Ares Capital Management LLC, a subsidiary of Ares Management LLC. The Company's investment objective is to generate current income and capital appreciation primarily through first and second lien senior secured loans, mezzanine debt, and to a lesser extent, equity investments in U.S. middle-market companies.
Key Financial Metrics
| Metric | 2013 | 2012 |
|---|---|---|
| Total Investment Income | $881.7 million | $748.0 million |
| Net Investment Income | $430.4 million | $348.9 million |
| Net Increase in Stockholders' Equity (Operations) | $488.5 million | $508.2 million |
| Total Assets | $8.14 billion | $6.40 billion |
| Total Debt (Principal) | $3.08 billion | $2.29 billion |
| Net Asset Value (NAV) per Share | $16.46 | $16.04 |
| Dividends Declared per Share | $1.57 | $1.60 |
| Weighted Average Yield (Fair Value) | 10.4% | 11.3% |
| Asset Coverage Ratio | 264% | 264% |
Material Changes vs. Prior Period
- Portfolio Growth: Total assets increased by approximately 27% to $8.14 billion, driven by significant equity issuances ($833.5 million in net proceeds) and debt capital activities.
- Income Growth: Total investment income rose 18% to $881.7 million, primarily due to a larger portfolio size (average amortized cost increased from $5.5 billion to $6.7 billion). Interest income increased to $647.9 million.
- Expense Increases: Total expenses increased to $437.2 million. Interest and credit facility fees rose to $171.5 million due to higher average debt principal and a slightly higher weighted average interest rate (5.3% vs 5.2%). Incentive fees related to net investment income increased to $110.5 million.
- Realized Gains: Net realized gains on investments were $63.7 million in 2013, compared to $46.7 million in 2012. This was offset by a net unrealized loss of $5.6 million in 2013, contrasting with a net unrealized gain of $115.3 million in 2012.
- Senior Secured Loan Program (SSLP): The Company's investment in the SSLP (a co-investment vehicle with GE) grew to approximately $1.8 billion at fair value, representing 23% of the total portfolio. Income from the SSLP accounted for approximately 33% of total investment income.
Guidance, Outlook, and Risks
Management Commentary: Management highlighted that the Company's investment performance was generally above average compared to comparable BDCs. The portfolio's weighted average credit grade remained stable at 3.0. The Company continues to focus on self-originating investments in middle-market companies, leveraging the Ares platform for deal flow.
Risks and Contingencies:
- Legal Proceedings: The Company is a defendant in a lawsuit filed by the bankruptcy trustee of DSI Renal Holdings LLC, alleging fraudulent transfer. The complaint seeks approximately $117 million in damages from Ares Capital. Management believes the claims are without merit and intends to vigorously defend the action.
- Market Risk: The Company faces risks related to capital market disruption, interest rate fluctuations, and the illiquidity of private investments. A significant portion of the portfolio (81%) bears variable interest rates, though 71% of these have interest rate floors.
- Leverage: The Company utilizes leverage to enhance returns. As of December 31, 2013, the ratio of total principal debt to stockholders' equity was 0.63:1.00. The Company must maintain an asset coverage ratio of at least 200% to incur additional debt or issue preferred stock.
- Conflicts of Interest: As an externally managed BDC, there are inherent conflicts regarding the allocation of investment opportunities between Ares Capital and other Ares funds, as well as the structure of management and incentive fees.
Key Facts for Investor Verification
- Dividend Sustainability: Verify the Company's ability to maintain dividend distributions given the requirement to distribute at least 90% of investment company taxable income to maintain RIC status, particularly in light of non-cash income (PIK interest) that must be paid out in cash.
- SSLP Concentration: Assess the risk concentration in the Senior Secured Loan Program (SSLP), which represents 23% of the portfolio and 33% of investment income. The Company's return on this investment is junior to GE's senior notes.
- Legal Exposure: Monitor the status of the DSI Renal Holdings litigation, which seeks $117 million in damages, and any potential impact on financial condition.
- Debt Maturity Profile: Review the maturity schedule of the $3.08 billion in debt, noting that a significant portion consists of convertible notes and unsecured notes with maturities ranging from 2016 to 2047.
- Valuation Methodology: Understand that 100% of the portfolio is valued at fair value, with a significant portion (investments without readily available market quotations) valued by the Board of Directors using unobservable inputs, which introduces estimation risk.